Skip to content

Clinical trials

Phase 3 Lymphatic Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphatic Metastasis Phase: Phase 3 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20092
20161
20181
20192
20201
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status3
Active, not recruiting2
Not yet recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital1
Fudan University1
Fujian Medical University1
Johannes Gutenberg University Mainz1
National Cancer Institute (NCI)1
Qilu Pharmaceutical Co., Ltd.1
Queensland Centre for Gynaecological Cancer1
RDO Pharm.1
Samsung Medical Center1
Shanghai Chest Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphatic Metastasis12
Lung Neoplasms2
Thyroid Neoplasms2
Uterine Cervical Neoplasms2
Adenocarcinoma of Lung1
Bronchial Neoplasms1
Carcinoma, Bronchogenic1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Carcinoma, Squamous Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.